Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria

Fig. 6

Effects of BM-MSC therapy on renal function in P. berghei-infected animals. Mice were infected with P. berghei or mock-infected with saline and, 24 hours after infection, treated with BM-MSCs. Five days after infection, plasma and urine samples were collected for analysis of renal function. Analysis of a urinary flow, b plasma creatinine, c blood urea nitrogen (BUN), d creatinine clearance, e BUN/plasma creatinine, f urinary creatinine, and g urinary protein/creatinine ratio (UPCr) in different experimental groups is depicted. Values are expressed as mean ± SD of six animals per group out of two experiments. *Significantly different from uninfected group (p <0.05). +Significantly different from P. berghei-infected group (p <0.05). BM-MSC bone marrow-derived mesenchymal stromal cell, UPC urinary protein/creatinine

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512